Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Reduced testosterone levels in males with lone atrial fibrillation.

    Lai J, Zhou D, Xia S, Shang Y, Want L, Zheng L, Zhu J.

    Clin Cardiol. 2009 Jan;32(1):43-6.PMID: 19143004 [PubMed - indexed for MEDLINE]Related articles

    2.

    Optimizing treatment success with an amylin analogue.

    Want LL.

    Diabetes Educ. 2008 Jan-Feb;34 Suppl 1:11S-7S.PMID: 18268001 [PubMed - indexed for MEDLINE]Related articles

    3.

    Case study 3: balancing act: using a team approach to achieve better glycemic control for the patient with type 2 diabetes.

    Want LL.

    Diabetes Educ. 2007 Jan-Feb;33 Suppl 1:20S-26S. No abstract available. PMID: 17272805 [PubMed - indexed for MEDLINE]Related articles

    4.

    Exenatide and pramlintide: new therapies for diabetes.

    Want LL, Ratner R.

    Int J Clin Pract. 2006 Dec;60(12):1522-3. No abstract available. PMID: 17109659 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pramlintide: A new tool in diabetes management.

    Want LL, Ratner RE.

    Curr Diab Rep. 2006 Nov;6(5):344-9. Review.PMID: 17076994 [PubMed - indexed for MEDLINE]Related articles

    6.

    Use of pramlintide: the patient's perspective.

    Want L.

    Diabetes Educ. 2006 May-Jun;32 Suppl 3:111S-118S.PMID: 16751352 [PubMed - indexed for MEDLINE]Related articles

    7.

    Overview of diabetes.

    Bardsley JK, Want LL.

    Crit Care Nurs Q. 2004 Apr-Jun;27(2):106-12. Review.PMID: 15137353 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

    Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.

    Diabetes Care. 2003 Jan;26(1):1-8.PMID: 12502651 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes.

    Ratner RE, Want LL, Fineman MS, Velte MJ, Ruggles JA, Gottlieb A, Weyer C, Kolterman OG.

    Diabetes Technol Ther. 2002;4(1):51-61.PMID: 12017421 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...